QA: Inmed Pharmaceuticals Inc in us_pharma/2024

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001728328_2025_Inmed_Pharmaceuticals_Inc.pdf

Logs

warning The EntityCommonStockSharesOutstanding does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001728328, Inmed Pharmaceuticals Inc

  xvar xval
0 AssetsCurrent 8,689,585
1 IntangibleAssetsNetIncludingGoodwill 1,783,198
2 PropertyPlantAndEquipmentNet 1,249,999
3 remainder_Assets 100,000
4 LiabilitiesCurrent 1,971,808
5 LiabilitiesNoncurrent 644,865
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 4,429,146
8 SellingGeneralAndAdministrativeExpense 5,781,969
9 ResearchAndDevelopmentExpense 3,293,644
10 remainder_Expenses 279,974
11 remainder_Revenues 4,971,177
12 remainder_NetIncome 524,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 11,822,782
1 Liabilities 2,616,673
2 Expenses 13,784,733
3 Revenues 4,971,177
4 StockholdersEquity 9,206,109
5 NetIncome -8,289,556
6 ComprehensiveNetIncome -8,289,556
7 BaseVar 16,859,682
8 EconomicCapitalRatiobeforeLimitedLiability 1.63
9 EconomicCapitalRatio 2.77

Edgar->Model Mapping

Feature Distribution

Change over Time